Biovitrum's Annual Report 2009 now available online
(Thomson Reuters ONE) -
Swedish Orphan Biovitrum announces that Biovitrum AB (publ)´s complete Annual
Report 2009 now is available as a PDF document for downloading or reading
atwww.biovitrum.com
Biovitrum's Annual General Meeting will be held April 27, 2010.
For more information please contact:
Swedish Orphan Biovitrum
Martin Nicklasson, CEO
Phone: +46 8 697 20 00
Göran Arvidson, CFO
Cell phone: +46 70 633 30 42
Erik Kinnman, EVP Investor Relations
Cell phone: +46 73 422 15 40
erik.kinnman(at)biovitrum.com
About Swedish Orphan Biovitrum
On January 14, 2010, Biovitrum AB (publ) completed the acquisition of Swedish
Orphan International Holding AB and created Swedish Orphan Biovitrum - a leading
company focused on treatment of rare diseases.
Swedish Orphan Biovitrum is a Swedish based specialty pharmaceutical company
with an international market presence. The company is focused on providing and
developing orphan and niche specialist pharmaceuticals to patients with high
medical needs. The portfolio consists of about 60 marketed products and an
emerging late stage clinical development pipeline within rare diseases. Swedish
Orphan Biovitrum has pro-forma revenues 2009e of about 2 BSEK and approximately
500 employees. The head office is located in Sweden and the share (STO: BVT) is
listed on NASDAQ OMX Stockholm. For more information please visit
www.biovitrum.com
[HUG#1403103]
Press release April 13: http://hugin.info/134557/R/1403103/357477.pdf
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.04.2010 - 08:01 Uhr
Sprache: Deutsch
News-ID 1012795
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Stockholm
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 96 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biovitrum's Annual Report 2009 now available online
"
steht unter der journalistisch-redaktionellen Verantwortung von
Biovitrum (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
